Helmy Eltoukhy - Dec 31, 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Co-Chief Executive Officer, Director
Signature
/s/ John G. Saia, as attorney-in-fact for Helmy Eltoukhy
Stock symbol
GH
Transactions as of
Dec 31, 2024
Transactions value $
-$1,500,555
Form type
4
Date filed
1/3/2025, 05:52 PM
Previous filing
Oct 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +11.5K +0.5% $0.00 2.32M Dec 31, 2024 Direct
transaction GH Common Stock Tax liability -$177K -5.81K -0.25% $30.55 2.31M Dec 31, 2024 Direct F1
transaction GH Common Stock Options Exercise $0 +94.6K +4.09% $0.00 2.4M Jan 1, 2025 Direct
transaction GH Common Stock Tax liability -$1.32M -43.3K -1.8% $30.55 2.36M Jan 1, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -11.5K -100% $0.00 0 Dec 31, 2024 Common Stock 11.5K $0.00 Direct F2, F3
transaction GH Restricted Stock Units Options Exercise $0 -94.6K -33% $0.00 192K Jan 1, 2025 Common Stock 94.6K $0.00 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 This restricted stock unit award was granted on March 18, 2024 and vests in four equal installments on the last day of each calendar quarter, March 31st, June 30th, September 30th, and December 31st, 2024.
F3 Not applicable for Restricted Stock Units.
F4 This restricted stock unit award was granted on March 18, 2024 and vests with respect to 1/3 of the shares on January 1, 2025, and then quarterly for the remaining twenty-four months.